These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4197709)

  • 1. Synthesis of actinomycin D lactam, [1',1'-bis(L-threo- , -diaminobutyric acid)]actinomycin D.
    Atherton E; Patel RP; Sano Y; Meienhofer J
    J Med Chem; 1973 Apr; 16(4):355-8. PubMed ID: 4197709
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of an actinomycin analog with substituted lactone oxygens (1',1'-bis(L-,-diaminopropionic acid))-actinomycin C (C 1).
    Meienhofer J; Patel RP
    Int J Protein Res; 1971; 3(6):347-50. PubMed ID: 5289931
    [No Abstract]   [Full Text] [Related]  

  • 3. 7-substituted actinomycin D analogs. Chemical and growth-inhibitory studies.
    Sengupta SK; Tinter SK; Lazarus H; Brown BL; Modest EJ
    J Med Chem; 1975 Dec; 18(12):1175-80. PubMed ID: 1059773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some properties and antitumor effects of the actinomycin lactam analog, (di(1-L-alpha, beta-diaminopropionic))actinomycin D1.
    Moore S; Patel RP; Atherton E; Kondo M; Meienhofer J
    J Med Chem; 1976 Jun; 19(6):766-72. PubMed ID: 950643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some observations on the action of actinomycin D, mitomycin C and jawaharene on transplanted mouse fibrosarcoma.
    Roy A; Chatterjee PC
    Indian J Cancer; 1974 Dec; 11(4):394-8. PubMed ID: 4468244
    [No Abstract]   [Full Text] [Related]  

  • 6. The enhanced response of the Ridgway osteogenic sarcoma to roentgen radiation combined with actinomycin D.
    D'Angio GJ; Maddock CL; Farber S; Brown BL
    Cancer Res; 1965 Aug; 25(7):1002-7. PubMed ID: 5214993
    [No Abstract]   [Full Text] [Related]  

  • 7. Actinomycin D: effects on Ridgway osteogenic sarcoma in mice.
    Schwartz HS; Sodergren JE; Sternberg SS; Philips FS
    Cancer Res; 1966 Sep; 26(9):1873-9. PubMed ID: 5224225
    [No Abstract]   [Full Text] [Related]  

  • 8. The fate of liposome-entrapped actinomycin D in vivo and its therapeutic effect in a solid murine tumour [proceedings].
    Kaye SB; Ryman BE
    Biochem Soc Trans; 1980 Feb; 8(1):107-8. PubMed ID: 6929266
    [No Abstract]   [Full Text] [Related]  

  • 9. Syntheses of actinomycin and analogs. 8. A synthesis of actinomycin D lactam.
    Atherton E; Meienhofer J
    J Am Chem Soc; 1972 Jun; 94(13):4759-61. PubMed ID: 5036171
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results.
    Lasek W; Giermasz A; Kuc K; Wańkowicz A; Feleszko W; Gołab J; Zagozdzon R; Stokłosa T; Jakóbisiak M
    Int J Cancer; 1996 May; 66(3):374-9. PubMed ID: 8621260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon-7 substituted actinomycin D analogues as improved antitumor agents: synthesis and DNA-binding and biological properties.
    Sengupta SK; Anderson JE; Kelley C
    J Med Chem; 1982 Oct; 25(10):1214-9. PubMed ID: 7143358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histological analysis of the effect of individual actinomycins on animal organs and tumors].
    Zubova OV; Shorokhova AA; Silaev AB
    Antibiotiki; 1969 Jun; 14(7):616-20. PubMed ID: 4185521
    [No Abstract]   [Full Text] [Related]  

  • 13. Actinomycin D effects on nucleic acids during tumor regression.
    Schwartz HS; Sodergren JE
    Cancer Res; 1968 Mar; 28(3):445-51. PubMed ID: 5238558
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 May; 62(5):779-89. PubMed ID: 77730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of peptide analogs of actinomycin D (NSC-3053).
    Meienhofer J
    Cancer Chemother Rep; 1974; 58(1):21-34. PubMed ID: 4812835
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of Rous sarcoma virus genome in AKR mouse sarcoma cells resistant to chromomycin A 3 and actinomycin D.
    Kuwata T; Sekiya S
    Arch Gesamte Virusforsch; 1972; 37(4):386-90. PubMed ID: 4114279
    [No Abstract]   [Full Text] [Related]  

  • 17. Disposition of [3H]actinomycin D in tumor-bearing mice.
    Galbraith WM; Mellett LB
    Cancer Res; 1976 Apr; 36(4):1242-5. PubMed ID: 1063063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours.
    Kaye SB; Boden JA; Ryman BE
    Eur J Cancer (1965); 1981 Mar; 17(3):279-89. PubMed ID: 6943028
    [No Abstract]   [Full Text] [Related]  

  • 19. Production, biological and therapeutic properties of some individual actinomycins.
    Silayev AB; Nefelova MV; Kuznetsova VS; Zubova OV; Akopyants SS; Orlova TI
    Neoplasma; 1968; 15(6):623-8. PubMed ID: 4178640
    [No Abstract]   [Full Text] [Related]  

  • 20. Different sensitivity to actinomycin D of biopsies of human tumors cultivated in vitro.
    Morasca L; Balconi G
    Eur J Cancer (1965); 1973 Apr; 9(4):301-4. PubMed ID: 4521544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.